Literature DB >> 9482772

Chronic exposure to secoisolariciresinol diglycoside alters lignan disposition in rats.

S E Rickard1, L U Thompson.   

Abstract

Mammalian lignans from colonic bacterial action on secoisolariciresinol diglycoside (SDG) may mediate the anticarcinogenic effect of prolonged SDG feeding in rats. To elucidate lignan bioactivity, our objective was to determine 3H-SDG disposition in rats with acute or chronic SDG treatment over 48 h. After food deprivation overnight, female Sprague-Dawley rats (70-72 d old) were given a single gavage of 3H-SDG (3.7 kBq/g body weight) either immediately (acute, n = 12) or after 10 d of gavage with 1.5 mg unlabeled SDG/d (chronic, n = 12). Rats were killed at 12, 24, 36 and 48 h after gavage, and samples collected and analyzed for radioactivity by liquid scintillation counting. Radioactivity was 1- to 16-fold higher at 12 vs. 48 h for tissues, blood and gastrointestinal contents (P < 0.05). By 48 h, >80% of the recovered dose was excreted in both groups (feces > 50%, urine = 28-32%). Tissue radioactivity was highest (by 0.5- to 176-fold) in the cecum (P < 0.05). Levels in the liver, kidney and uterus (12 h) were 0.2- to 7.5-fold higher than in other nongastrointestinal tissues. At 12 h, fecal radioactivity was negligible, and cecal content, liver and adipose radioactivity were one- to threefold greater in rats with chronic SDG exposure than in those acutely exposed (P < 0.05). Blood radioactivity, present mostly in the plasma fraction (0.4% of dose), suggested that lignan concentrations could be 3000 times higher than peak estrogen levels in rats. Thus, SDG metabolites accumulated in the liver, kidney, intestinal tissues and uterus. Chronic SDG exposure delayed fecal excretion while increasing liver and adipose lignan levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482772     DOI: 10.1093/jn/128.3.615

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  4 in total

1.  Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.

Authors:  D D Kitts; Y V Yuan; A N Wijewickreme; L U Thompson
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Effect of dietary intervention on serum lignan levels in pregnant women - a controlled trial.

Authors:  Riitta Luoto; Elham Kharazmi; Niina M Saarinen; Annika I Smeds; Sari Mäkelä; Mahdi Fallah; Jani Raitanen; Leena Hilakivi-Clarke
Journal:  Reprod Health       Date:  2010-10-08       Impact factor: 3.223

3.  Flaxseed modulates inflammatory and oxidative stress biomarkers in cystic fibrosis: a pilot study.

Authors:  Jason B Turowski; Ralph A Pietrofesa; John A Lawson; Melpo Christofidou-Solomidou; Denis Hadjiliadis
Journal:  BMC Complement Altern Med       Date:  2015-05-13       Impact factor: 3.659

Review 4.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.